Artwork

İçerik CITI Program tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan CITI Program veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Player FM - Podcast Uygulaması
Player FM uygulamasıyla çevrimdışı Player FM !

The Evolution of IRBs: Navigating Ethical Considerations in Research - On Research Podcast

49:31
 
Paylaş
 

Manage episode 425582715 series 3435518
İçerik CITI Program tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan CITI Program veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

Join us for a thoughtful, long-form discussion about the evolving IRB Industry. Julie Blasingim, the CEO of Univo IRB, sits down to talk about how we got to the current IRB landscape we have now, and the future of IRBs. She covers a lot of areas related to the IRB, including how for-profit IRBs balance ethical reviews with the economics of business, identifying the gap between patients and the IRB process, as well as some hot topics for the IRB, like growing privacy protection concerns and the impact of AI on the IRB process.
Additional Resources:

Guest Bio: Julie Blasingim, CEO of Univo IRB, is a seasoned IRB executive with 20 years of extensive regulatory, operational, and compliance experience in human research protection and site operations of clinical research. She has served in a dozen senior leadership roles across multiple central IRBs, has hosted countless FDA inspections at both the IRB and under-site operations, and has managed multiple accreditations and certifications through AAHRPP and ISO. Julie holds a master’s degree in business administration specializing in leadership.

  continue reading

Bölümler

1. The Evolution of IRBs: Navigating Ethical Considerations in Research - On Research Podcast (00:00:00)

2. Introduction to Julie Blasingim (00:01:02)

3. Julie's Journey into the Research Industry (00:01:42)

4. Evolution of Independent IRBs (00:03:02)

5. IRB Landscape Changes (00:07:09)

6. Managing Ethical Concerns in For-Profit (00:15:30)

7. Disconnect Between IRBs and Patients (00:19:54)

8. IRBs' Unique Position (00:23:45)

9. Patient-Centric Approach (00:24:46)

10. IRBs' Evolution (00:26:14)

11. Ethical Concerns in Research (00:28:29)

12. IT Security and IRB Boards (00:31:22)

13. AI Impact on IRBs (00:33:52)

14. Ethical Framework and Decision-Making (00:40:10)

15. Balancing Risk and Patient Empowerment (00:43:09)

16. Same Team: Impactful Research (00:46:37)

17. Closing Remarks (00:48:57)

22 bölüm

Artwork
iconPaylaş
 
Manage episode 425582715 series 3435518
İçerik CITI Program tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan CITI Program veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

Join us for a thoughtful, long-form discussion about the evolving IRB Industry. Julie Blasingim, the CEO of Univo IRB, sits down to talk about how we got to the current IRB landscape we have now, and the future of IRBs. She covers a lot of areas related to the IRB, including how for-profit IRBs balance ethical reviews with the economics of business, identifying the gap between patients and the IRB process, as well as some hot topics for the IRB, like growing privacy protection concerns and the impact of AI on the IRB process.
Additional Resources:

Guest Bio: Julie Blasingim, CEO of Univo IRB, is a seasoned IRB executive with 20 years of extensive regulatory, operational, and compliance experience in human research protection and site operations of clinical research. She has served in a dozen senior leadership roles across multiple central IRBs, has hosted countless FDA inspections at both the IRB and under-site operations, and has managed multiple accreditations and certifications through AAHRPP and ISO. Julie holds a master’s degree in business administration specializing in leadership.

  continue reading

Bölümler

1. The Evolution of IRBs: Navigating Ethical Considerations in Research - On Research Podcast (00:00:00)

2. Introduction to Julie Blasingim (00:01:02)

3. Julie's Journey into the Research Industry (00:01:42)

4. Evolution of Independent IRBs (00:03:02)

5. IRB Landscape Changes (00:07:09)

6. Managing Ethical Concerns in For-Profit (00:15:30)

7. Disconnect Between IRBs and Patients (00:19:54)

8. IRBs' Unique Position (00:23:45)

9. Patient-Centric Approach (00:24:46)

10. IRBs' Evolution (00:26:14)

11. Ethical Concerns in Research (00:28:29)

12. IT Security and IRB Boards (00:31:22)

13. AI Impact on IRBs (00:33:52)

14. Ethical Framework and Decision-Making (00:40:10)

15. Balancing Risk and Patient Empowerment (00:43:09)

16. Same Team: Impactful Research (00:46:37)

17. Closing Remarks (00:48:57)

22 bölüm

Tutti gli episodi

×
 
Loading …

Player FM'e Hoş Geldiniz!

Player FM şu anda sizin için internetteki yüksek kalitedeki podcast'leri arıyor. En iyi podcast uygulaması ve Android, iPhone ve internet üzerinde çalışıyor. Aboneliklerinizi cihazlar arasında eş zamanlamak için üye olun.

 

Hızlı referans rehberi